Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
3 Healthcare Stocks That Should Be on Every Investor's Radar This Fall
09:00am, Saturday, 23'rd Sep 2023
As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date (YTD) performance is the second worst only behind utilities.
2 Healthcare Stocks That Could Make You Richer
10:07am, Friday, 22'nd Sep 2023
Vertex has almost no weak spots thanks to a solid core franchise and several promising programs. DexCom is helping improve the lives of diabetes patients, and the company still has lots of room to gro
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
02:37pm, Thursday, 21'st Sep 2023
A remarkable 30-year bull run for the Nasdaq 100 saw it gain nearly 4,000% by 2020. But, the party came to a screeching halt when the pandemic hit.
DexCom (DXCM) Launches Latest CGM Sensor ONE in France
09:02am, Monday, 18'th Sep 2023
DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.
Will DexCom Stock Recover To Its Pre-Inflation Shock Highs Of $160?
09:00am, Monday, 18'th Sep 2023
The notable increase in DexCom's revenues over recent quarters has also contributed to the stock recovery.
Why DexCom Stock Dove by 5% Today
06:11pm, Friday, 15'th Sep 2023
A Raymond James analyst cut his price target on the specialty medical device maker. It was the second such price target cut so far this month.
Here's Why You Should Retain DexCom (DXCM) Stock for Now
09:01am, Thursday, 14'th Sep 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom (DXCM) Rises 7% in One Week: What's Driving It?
09:50am, Tuesday, 12'th Sep 2023
DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.
With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?
06:00am, Friday, 08'th Sep 2023
We believe DexCom stock (NASDAQ: DXCM) is a better healthcare pick than Intuitive Surgical stock (NASDAQ: ISRG).
Dexcom Denies Weight Loss Drug Threat To CGM Sales - I'd Be A Little Concerned
11:41am, Thursday, 07'th Sep 2023
DexCom is a major player in the continuous glucose monitoring space, with steadily growing revenues and a breakout year in 2020. DXCM's market cap valuation has reached $40 billion, leading to high ex
DexCom's (DXCM) G6 CGM Connects With Omnipod 5 AID in Germany
09:01am, Tuesday, 05'th Sep 2023
DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.
What's Next For DexCom Stock After A 17% Fall In A Month?
09:00am, Friday, 01'st Sep 2023
DexCom stock (NASDAQ: DXCM) has seen a 17% fall in a month, compared to a 2% fall for the broader S&P500 index.
Is Trending Stock DexCom, Inc. (DXCM) a Buy Now?
10:31am, Wednesday, 30'th Aug 2023
Recently, Zacks.com users have been paying close attention to DexCom (DXCM). This makes it worthwhile to examine what the stock has in store.
Dexcom Announces Upcoming Conference Presentations
08:30am, Wednesday, 30'th Aug 2023
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: Jereme Sylvain, Executive V
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
10:00am, Tuesday, 22'nd Aug 2023
CRISPR Therapeutics is using a novel technique to develop innovative therapies. Sarepta Therapeutics is developing medicines targeting a difficult-to-treat disease.
